Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Bauer

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Journal of Thrombosis and Haemostasis : JTH|July 2, 2025
Glucagon-like peptide 1 receptor agonists and risk of venous thromboembolism: a systematic review and meta-analysis of randomized controlled trialsCho-Han Chiang, Yu-Cheng Chang, Chun-Chiao Yu, et al.
Annals of Internal Medicine|January 7, 2015
D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort studyClive Kearon, Frederick A Spencer, Denis O'Keeffe, et al.
The New England Journal of Medicine|February 26, 2003
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolismPaul M Ridker, Samuel Z Goldhaber, Ellie Danielson, et al.
The American Journal of Medicine|May 17, 2020
Changes in Care for Acute Pulmonary Embolism Through A Multidisciplinary Pulmonary Embolism Response TeamBrett J Carroll, Sebastian E Beyer, Tyler Mehegan, et al.
Blood|March 2, 2018
Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolismClive Kearon, Sameer Parpia, Frederick A Spencer, et al.
Blood Advances|November 29, 2018
American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patientsHolger J Schünemann, Mary Cushman, Allison E Burnett, et al.
Blood Advances|October 13, 2020
Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviewsAndrea J Darzi, Allen B Repp, Frederick A Spencer, et al.
The New England Journal of Medicine|February 21, 2019
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with CancerAlok A Khorana, Gerald A Soff, Ajay K Kakkar, et al.
Nature Medicine|July 12, 2020
Extrapulmonary manifestations of COVID-19Aakriti Gupta, Mahesh V Madhavan, Kartik Sehgal, et al.
Annals of Internal Medicine|January 25, 2021
Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19Hanny Al-Samkari, Shruti Gupta, Rebecca Karp Leaf, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Journal of Thrombosis and Haemostasis : JTH|July 2, 2025
Glucagon-like peptide 1 receptor agonists and risk of venous thromboembolism: a systematic review and meta-analysis of randomized controlled trialsCho-Han Chiang, Yu-Cheng Chang, Chun-Chiao Yu, et al.
Annals of Internal Medicine|January 7, 2015
D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort studyClive Kearon, Frederick A Spencer, Denis O'Keeffe, et al.
The New England Journal of Medicine|February 26, 2003
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolismPaul M Ridker, Samuel Z Goldhaber, Ellie Danielson, et al.
The American Journal of Medicine|May 17, 2020
Changes in Care for Acute Pulmonary Embolism Through A Multidisciplinary Pulmonary Embolism Response TeamBrett J Carroll, Sebastian E Beyer, Tyler Mehegan, et al.
Blood|March 2, 2018
Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolismClive Kearon, Sameer Parpia, Frederick A Spencer, et al.
Blood Advances|November 29, 2018
American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patientsHolger J Schünemann, Mary Cushman, Allison E Burnett, et al.
Blood Advances|October 13, 2020
Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviewsAndrea J Darzi, Allen B Repp, Frederick A Spencer, et al.
The New England Journal of Medicine|February 21, 2019
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with CancerAlok A Khorana, Gerald A Soff, Ajay K Kakkar, et al.
Nature Medicine|July 12, 2020
Extrapulmonary manifestations of COVID-19Aakriti Gupta, Mahesh V Madhavan, Kartik Sehgal, et al.
Annals of Internal Medicine|January 25, 2021
Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19Hanny Al-Samkari, Shruti Gupta, Rebecca Karp Leaf, et al.
Pageof 10